BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
243 hedge funds and large institutions have $6.9B invested in bluebird bio in 2017 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 105 increasing their positions, 61 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 241 → 243 (+2)
0% more ownership
Funds ownership: 8.51% → 8.51% (+0%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
243
Holding in Top 10
3
Calls
$163M
Puts
$110M
Top Buyers
| 1 | +$48.9M | |
| 2 | +$38.4M | |
| 3 | +$34M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$31.2M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$29.5M |
Top Sellers
| 1 | -$30.8M | |
| 2 | -$28.4M | |
| 3 | -$25M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$21.7M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$21.1M |